尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Pasqualone Frank, Vice-Président. Officer active across 2 companies, notably Theravance Biopharma, Inc.. In total, 6 filings have been recorded. Split: 1 buy · 0 sell. Total volume traded: €2k. Activity tracked since 20 May 2021. The latest transaction was disclosed on 23 December 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Frank Pasqualone is the Senior Vice President and Chief Business Officer at Theravance Biopharma, Inc. He is responsible for commercial strategy and business development. His expertise contributes to the growth and innovation of the company.